KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 103 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $29,453,000 | +55.2% | 587,300 | +7.3% | 0.01% | +60.0% |
| Q4 2014 | $18,980,000 | +5.9% | 547,300 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $17,930,000 | -14.6% | 547,300 | 0.0% | 0.01% | -16.7% |
| Q2 2014 | $21,000,000 | -3.5% | 547,300 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $21,761,000 | +16.8% | 547,300 | +9.4% | 0.01% | +20.0% |
| Q4 2013 | $18,636,000 | +25.5% | 500,300 | +53.9% | 0.01% | 0.0% |
| Q3 2013 | $14,853,000 | +69.0% | 325,000 | 0.0% | 0.01% | +66.7% |
| Q2 2013 | $8,791,000 | – | 325,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 34,925 | $1,596,000 | 1.83% |
| Redmile Group, LLC | 228,218 | $10,430,000 | 1.57% |
| Palo Alto Investors LP | 319,113 | $14,548,000 | 1.52% |
| Aureus Asset Management, LLC | 92,350 | $4,210,000 | 1.44% |
| PFM Health Sciences, LP | 767,892 | $35,007,000 | 0.84% |
| EAM Investors, LLC | 60,219 | $2,752,000 | 0.55% |
| INVESTOR AB | 80,000 | $3,540,000 | 0.41% |
| Partner Investment Management, L.P. | 23,595 | $1,076,000 | 0.29% |
| Polar Capital LLP | 230,000 | $10,511,000 | 0.28% |
| Old West Investment Management, LLC | 11,130 | $507,000 | 0.24% |